Scientists at NYU College of Dentistry’s Pain Research Center have made a groundbreaking discovery in the treatment of chronic pain. They have developed a gene therapy that targets a specific sodium ion channel called NaV1.7, which has been shown to play a key role in the sensation of pain.
In their research, the scientists identified a regulatory protein called CRMP2 that binds to the NaV1.7 channel and controls its activity. By blocking the conversation between NaV1.7 and CRMP2, the researchers were able to prevent excessive sodium from entering the channel, effectively quieting down the neuron and providing relief from pain.
To deliver this therapy, the researchers created a peptide from the channel that corresponds to the region where CRMP2 binds to NaV1.7. They used an adeno-associated virus to deliver this peptide to neurons, inhibiting the activity of NaV1.7 and providing pain relief.
The effectiveness of this gene therapy has been tested in both cells and animals. In animal experiments, the engineered virus successfully reversed pain in mice experiencing sensitivity to touch, heat, cold, and peripheral neuropathy resulting from chemotherapy. Importantly, these findings have been replicated across multiple species, including rodents and the cells of primates and humans.
The promising results of this research have led the scientists to believe that their gene therapy approach holds great potential for the treatment of chronic pain in humans. While further studies are needed to fully understand and optimize this therapy, the researchers are hopeful that it could eventually lead to effective treatments for chronic pain conditions such as chemotherapy-induced neuropathy.
Chronic pain affects millions of people worldwide, often leading to reduced quality of life and significant healthcare costs. Current pain management options, such as opioids, often come with unwanted side effects and the risk of addiction. The development of a gene therapy that directly targets the underlying mechanisms of pain could revolutionize the field of pain management and provide much-needed relief for those suffering from chronic pain.
The researchers at NYU College of Dentistry’s Pain Research Center are now dedicated to further studying and refining this gene therapy. Their ultimate goal is to translate their findings into safe and effective treatments for chronic pain in humans, offering hope to the millions who currently have limited options for pain relief.
For more information on this groundbreaking research and updates on its progress, visit the ‘Road Rug Cars’ website.
“Infuriatingly humble tv expert. Friendly student. Travel fanatic. Bacon fan. Unable to type with boxing gloves on.”